Scientists at the Hebrew University of Jerusalem successfully trialed TriCor (fenofibrate see here previously) on 15 severely ill Covid patients. 14 were weaned off their ventilators within a week. TriCor targets inflammation-producing lipids produced by the coronavirus.
Covid trial of cholesterol treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.